Leading pharmacy benefit managers are shifting away from lucrative rebates on biologic drugs and toward lower-cost biosimilar ...

N.B. Power rates for residential customers are lower than those in most neighbouring jurisdictions, but they have also risen ...

We are very happy to have been granted a meeting with the FDA to review the positive OnTarget results in breast cancer patients and our goal is to discuss the most efficient pathways to make ...

The federal 340b Drug Pricing program allows hospitals or health centers to receive prescription medications ... that partake in the 340b program can only provide the drugs they receive at ...

India may soon have its first list of drugs moving from prescription-only to over-the-counter ... Prakash’s panel will only recommend the list for consideration to the Drug Technical Advisory Board ...

Two Fiji Corrections Service officers have been dismissed following their involvement in a drug-related incident uncovered during a recent police operation. During a raid conducted by police at a ...

TREMFYA ® is the only IL-23i to demonstrate clinical remission ... in Crohn's disease builds upon recent ulcerative colitis FDA approval, marking the fourth indication for this dual-acting ...

A new study has discovered what researchers say is the first drug to fully reproduce the effects ... rehabilitation which has shown to be only modestly effective. "The goal is to have a medicine ...

It's a milestone in medical research, largely because there's no drug that has proven effective in rehabilitation, leaving patients with only physical therapy to help rebuild the brain's signaling ...

has received U.S. Food and Drug Administration (FDA) approval for the treatment of adults with C3 glomerulopathy (C3G), to reduce proteinuria, making it the first and only treatment approved for this ...

Optum Rx said it plans to apply the policy to additional drugs in the future. Prior authorization requires doctors to get approval from a patient’s health or drug plan before providing a medical ...

IMVT-1402 would be the only drug in its class positioned to launch in an autoinjector, according to Immunovant. That may allow patients to self-administer the drug at home, per the company’s website.